Principaux documents

Voir toute la documentation

Passer à

50737-U

Ascentis^® Express 90 Å RP-Amide (5 μm) HPLC Columns

Name: Ascentis<SUP>&#174;</SUP> Express 90 Å RP-Amide (5 μm) HPLC Columns
Brand: SUPELCO
Price: 764 EUR

L × I.D. 10 cm × 2.1 mm, HPLC Column

Se connecter pour consulter les tarifs organisationnels et contractuels.

Sélectionner une taille de conditionnement

Changer de vue

Conditionnement	Référence	Disponibilité	Prix
1 ea		Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.	764,00 €

A propos de cet article

UNSPSC Code:

41115700

NACRES:

SB.52

L × i.d.:

10 cm × 2.1 mm

Particle size:

5 μm

Matrix active group:

RP Amide, amide, alkyl phase

Pore size:

90 Å pore size

Matrix:

Fused-Core^® particle platform, superficially porous particle

764,00 €

Veuillez contacter notre Service Clients pour connaître la disponibilité de ce produit.

Service technique

Besoin d'aide ? Notre équipe de scientifiques expérimentés est là pour vous.

Laissez-nous vous aider

Propriétés

Nom du produit

Ascentis^® Express RP-Amide, 5 μm HPLC Column, 5 μm particle size, L × I.D. 10 cm × 2.1 mm

material

stainless steel column

Quality Level

100

agency

suitable for USP L60

product line

Ascentis^®

feature

endcapped

manufacturer/tradename

Ascentis^®

packaging

1 ea of

parameter

60 °C temp. range, 600 bar max. pressure (9000 psi)

technique(s)

HPLC: suitable, LC/MS: suitable

L × I.D.

10 cm × 2.1 mm

surface area

90 m²/g

impurities

<5 ppm metals

matrix

Fused-Core^® particle platform, superficially porous particle

matrix active group

RP Amide, amide, alkyl phase

particle size

5 μm

pore size

90 Å pore size

pH range

2-9

application(s)

food and beverages

separation technique

reversed phase

Description

General description

Ascentis Express 5 μm RP-Amide is a high-speed, high-performance liquid chromatography column based on the highly efficient Fused-Core^® particle design. The Fused-Core particle provides a thin porous shell of high-purity silica surrounding a solid silica core. This particle design exhibits very high column efficiency due to the shallow diffusion paths in the 0.6 μm thick porous shell and the highly uniform overall particle size of 5 μm. The one-step bonded, endcapped, amide-based, polar-embedded stationary phase of Ascentis Express 5 μm RP-Amide provides a stable, reversed-phase packing with decreased hydrophobic character. Ascentis Express RP-Amide can be used for basic, acidic, or neutral compounds with orthogonal selectivity from C18 or C8. The polar-embedded Ascentis Express 5 μm RP-Amide columns are compatible with 100% aqueous mobile phases without suffering from “phase collapse”.

Other Notes

Discover LiChropur reagents ideal for HPLC or LC-MS analysis

Legal Information

Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany

Fused-Core is a registered trademark of Advanced Materials Technology, Inc.

Comparer avec des articles similaires

Voir la comparaison complète

Montrer les différences

1 of 1

Cet article	50753-U	50733-U	50734-U
Supelco 50737-U Ascentis^® Express RP-Amide, 5 μm HPLC Column	Supelco 50753-U Ascentis^® Express RP-Amide, 5 μm HPLC Column	Supelco 50733-U Ascentis^® Express RP-Amide, 5 μm HPLC Column	Supelco 50734-U Ascentis^® Express RP-Amide, 5 μm HPLC Column
matrix active group amide, alkyl phase	matrix active group amide, alkyl phase	matrix active group amide, alkyl phase	matrix active group amide, alkyl phase
L × I.D. 10 cm × 2.1 mm	L × I.D. 10 cm × 3 mm	L × I.D. 3 cm × 2.1 mm	L × I.D. 5 cm × 2.1 mm
particle size 5 μm	particle size 5 μm	particle size 5 μm	particle size 5 μm
separation technique reversed phase	separation technique reversed phase	separation technique reversed phase	separation technique reversed phase
technique(s) HPLC: suitable, LC/MS: suitable	technique(s) HPLC: suitable, LC/MS: suitable	technique(s) HPLC: suitable, LC/MS: suitable	technique(s) HPLC: suitable, LC/MS: suitable
pore size 90 Å pore size	pore size 90 Å pore size	pore size 90 Å pore size	pore size 90 Å pore size

Still not finding the right product?

Explore all of our products under

Faites votre choix parmi les versions les plus récentes :

Certificats d'analyse (COA)

Lot/Batch Number

Vous ne trouvez pas la bonne version ?

Si vous avez besoin d'une version particulière, vous pouvez rechercher un certificat spécifique par le numéro de lot.

Rechercher un(e) COA

Déjà en possession de ce produit ?

Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.

Consulter la Bibliothèque de documents

Contenu apparenté

Ascentis Express 5 um RP-Amide Column Care and Use Sheet

Ascentis® Express 5 μm RP-Amide Column Care & Use Sheet

A validated HPLC-MS/MS assay for quantifying unstable pharmacologically active metabolites of clopidogrel in human plasma: application to a clinical pharmacokinetic study.

Michael T Furlong et al.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 926, 36-41 (2013-04-02)

Clopidogrel is prescribed for the treatment of Acute Coronary Syndrome and recent myocardial infarction, recent stroke, or established peripheral arterial disease. A sensitive and reliable high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS) assay was developed and validated to enable reliable

Comparative study of new shell-type, sub-2 micron fully porous and monolith stationary phases, focusing on mass-transfer resistance.

Erzsébet Oláh et al.

Journal of chromatography. A, 1217(23), 3642-3653 (2010-04-23)

Today sub-2 microm packed columns are very popular to conduct fast chromatographic separations. The mass-transfer resistance depends on the particle size but some practical limits exist not to reach the theoretically expected plate height and mass-transfer resistance. Another approach applies

An HPLC-MS method for the quantification of new acetylcholinesterase inhibitor PC 48 (7-MEOTA-donepezil like compound) in rat plasma: Application to a pharmacokinetic study.

Martin Mzik et al.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 1020, 85-89 (2016-04-01)

A simple, rapid and sensitive method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been developed and validated for the quantitative determination in rat plasma of a new candidate for AD treatment, namely PC 48 (a 7-MEOTA-donepezil like compound) in

Afficher tous les articles scientifiques apparentés

Numéro d'article de commerce international

Référence	GTIN
50737-U	04061838528926
357782-1G	04061825584782

Questions

Reviews

No rating value